Reunion Neuroscience Inc. (REUN.TO) Research

Field Trip Health Ltd. is a company based in Toronto, Canada, that specializes in developing and delivering psychedelic-assisted therapies across North America. The firm manages Field Trip Health Centres, which administer psychedelic treatments, and offers Field Trip Digital applications. Additionally, through its Field Trip Discovery division, it conducts research to create innovative psychedelic molecules. The company provides ketamine-assisted therapy for various conditions, including depression, anxiety, and addiction. Field Trip Health Ltd. was founded in 2008.

Market snapshot

Symbol
REUN.TO
Price
$1.42
Day change
-2.74%
Market cap
$16.6M
P/E ratio
-0.34x
52-week range
0.83-9.44
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Antibe Therapeutics Inc. (ATE.TO)
  • Ayr Wellness Inc. (AYR-A.CN)
  • EXMceuticals Inc. (EXM.CN)
  • IM Cannabis Corp. (IMCC.CN)
  • IMV Inc. (IMV.TO)
  • LexaGene Holdings Inc. (LXG.V)
  • Numinus Wellness Inc. (NUMI.TO)
  • RIV Capital Inc. (RIV.CN)

Open Reunion Neuroscience Inc. (REUN.TO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.